Cantor Lifts Target on Hologic (HOLX) to $21; Q1 Solid, Buy Challenges Remain

February 4, 2014 7:59 AM

Cantor Fitzgerald is lifting its price target on Hologic, Inc. (Nasdaq: HOLX) from $19 up to $21, but maintains a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found